TY - JOUR
T1 - Propofol facilitates glutamatergic transmission to neurons of the ventrolateral preoptic nucleus
AU - Li, Ke Y.
AU - Guan, Yan Zhong
AU - Krnjević, Kresimir
AU - Ye, Jiang H.
PY - 2009/12
Y1 - 2009/12
N2 - BACKGROUND: There is much evidence that the sedative component of anesthesia is mediated by γ-aminobutyric acid type A (GABAA) receptors on hypothalamic neurons responsible for arousal, notably in the tuberomammillary nucleus. These GABAA receptors are targeted by γ-aminobutyric acid-mediated (GABAergic) neurons in the ventrolateral preoptic area (VLPO): When these neurons become active, they inhibit the arousal-producing nuclei and induce sleep. According to recent studies, propofol induces sedation by enhancing VLPO-induced synaptic inhibition, making the target cells more responsive to GABAA. The authors explored the possibility that propofol also promotes sedation less directly by facilitating excitatory inputs to the VLPO GABAergic neurons. METHODS: Spontaneous excitatory postsynaptic currents were recorded from VLPO cells-principally mechanically isolated, but also in slices from rats. RESULTS: In isolated VLPO GABAergic neurons, propofol increased the frequency of glutamatergic spontaneous excitatory postsynaptic currents without affecting their mean amplitude. The action of propofol was mimicked by muscimol and prevented by gabazine, respectively a specific agonist and antagonist at GABAA receptors. It was also suppressed by bumetanide, a blocker of Na-K-Cl cotransporter-mediated inward Cl transport. In slices, propofol also increased the frequency of spontaneous excitatory postsynaptic currents and, at low doses, accelerated firing of VLPO cells. CONCLUSION: Propofol induces sedation, at least in part, by increasing firing of GABAergic neurons in the VLPO, indirectly by activation of GABAA receptors on glutamatergic afferents: Because these axons/terminals have a relatively high internal Cl concentration, they are depolarized by GABAergic agents such as propofol, which thus enhance glutamate release.
AB - BACKGROUND: There is much evidence that the sedative component of anesthesia is mediated by γ-aminobutyric acid type A (GABAA) receptors on hypothalamic neurons responsible for arousal, notably in the tuberomammillary nucleus. These GABAA receptors are targeted by γ-aminobutyric acid-mediated (GABAergic) neurons in the ventrolateral preoptic area (VLPO): When these neurons become active, they inhibit the arousal-producing nuclei and induce sleep. According to recent studies, propofol induces sedation by enhancing VLPO-induced synaptic inhibition, making the target cells more responsive to GABAA. The authors explored the possibility that propofol also promotes sedation less directly by facilitating excitatory inputs to the VLPO GABAergic neurons. METHODS: Spontaneous excitatory postsynaptic currents were recorded from VLPO cells-principally mechanically isolated, but also in slices from rats. RESULTS: In isolated VLPO GABAergic neurons, propofol increased the frequency of glutamatergic spontaneous excitatory postsynaptic currents without affecting their mean amplitude. The action of propofol was mimicked by muscimol and prevented by gabazine, respectively a specific agonist and antagonist at GABAA receptors. It was also suppressed by bumetanide, a blocker of Na-K-Cl cotransporter-mediated inward Cl transport. In slices, propofol also increased the frequency of spontaneous excitatory postsynaptic currents and, at low doses, accelerated firing of VLPO cells. CONCLUSION: Propofol induces sedation, at least in part, by increasing firing of GABAergic neurons in the VLPO, indirectly by activation of GABAA receptors on glutamatergic afferents: Because these axons/terminals have a relatively high internal Cl concentration, they are depolarized by GABAergic agents such as propofol, which thus enhance glutamate release.
UR - http://www.scopus.com/inward/record.url?scp=73449084084&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=73449084084&partnerID=8YFLogxK
U2 - 10.1097/ALN.0b013e3181bf1d79
DO - 10.1097/ALN.0b013e3181bf1d79
M3 - Article
C2 - 19934872
AN - SCOPUS:73449084084
VL - 111
SP - 1271
EP - 1278
JO - Anesthesiology
JF - Anesthesiology
SN - 0003-3022
IS - 6
ER -